NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation

Journal of Proteome Research

Volumn 11, Issue 5, 2012, Pages 2996-3003

  Vermeer, Louic S ^a   Fruhwirth, Gilbert O ^a   Pandya, Pahini ^a   Ng, Tony ^a   Mason, A James ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

breast cancer cells; CXCR4; high resolution magic angle spinning (HR MAS); NMR metabolomics

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHOLINE; LIPID;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; COMPARATIVE STUDY; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHOLINE; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; METABOLOMICS; RATS; RECEPTORS, CXCR4; RETROVIRIDAE; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 84860642778     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300111x     Document Type: Article

References (38)

1. Gupta, S. K.; Pillarisetti, K. Cutting edge: CXCR4-Lo: molecular cloning and functional expression of a novel human CXCR4 splice variant J. Immunol. 1999, 163 (5) 2368-72
2. Caruz, A.; Samsom, M.; Alonso, J. M.; Alcami, J.; Baleux, F.; Virelizier, J. L.; Parmentier, M.; Arenzana-Seisdedos, F. Genomic organization and promoter characterization of human CXCR4 gene FEBS Lett. 1998, 426 (2) 271-8
3. Sun, X.; Cheng, G.; Hao, M.; Zheng, J.; Zhou, X.; Zhang, J.; Taichman, R. S.; Pienta, K. J.; Wang, J. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression Cancer Metastasis Rev. 2010, 29 (4) 709-22
4. Busillo, J. M.; Benovic, J. L. Regulation of CXCR4 signaling Biochim. Biophys. Acta 2007, 1768 (4) 952-63
5. Muller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M. E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S. N.; Barrera, J. L.; Mohar, A.; Verastegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis Nature 2001, 410 (6824) 50-6
6. Ueda, Y.; Neel, N. F.; Schutyser, E.; Raman, D.; Richmond, A. Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells Cancer Res. 2006, 66 (11) 5665-75
7. Fruhwirth, G. O.; Brock, A.; Keppler, M.; Khan, A.; Giampieri, S.; Sahai, E.; Gillet, C.; Ameer-Beg, S.; Archibald, S. J.; Ng, T. Receptor dimerization and degradation dampen the pro-metastatic effect of mutated CXCR4, Submitted.
8. Diaz, G. A. CXCR4 mutations in WHIM syndrome: a misguided immune system? Immunol. Rev. 2005, 203, 235-43
9. Balabanian, K.; Lagane, B.; Pablos, J. L.; Laurent, L.; Planchenault, T.; Verola, O.; Lebbe, C.; Kerob, D.; Dupuy, A.; Hermine, O.; Nicolas, J. F.; Latger-Cannard, V.; Bensoussan, D.; Bordigoni, P.; Baleux, F.; Le Deist, F.; Virelizier, J. L.; Arenzana-Seisdedos, F.; Bachelerie, F. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12 Blood 2005, 105 (6) 2449-57
10. Chabot, D. J.; Zhang, P. F.; Quinnan, G. V.; Broder, C. C. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates J. Virol. 1999, 73, 6598-609
11. Ierano, C.; Giuliano, P.; DAlterio, C.; Cioffi, M.; Mettivier, V.; Portella, L.; Napolitano, M.; Barbieri, A.; Arra, C.; Liguori, G..; Franco, R.; Palmieri, G..; Rozzo, C.; Pacelli, R.; Castello, G..; Scala, S. A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration Cell Cycle 2009, 8, 1228-37
12. Schüller, U.; Koch, A.; Hartmann, W.; Garrè, M. L.; Goodyer, C. G..; Cama, A.; Sörensen, N.; Wiestler, O. D.; Pietsch, T. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas Int. J. Cancer 2005, 117, 82-9
13. 1HMR spectroscopy J. Magn. Reson. Imaging 1999, 10 (2) 159-64
14. Thomas, M. A.; Wyckoff, N.; Yue, K.; Binesh, N.; Banakar, S.; Chung, H. K.; Sayre, J.; DeBruhl, N. Two-dimensional MR spectroscopic characterization of breast cancer in vivo Technol. Cancer Res. Treat. 2005, 4 (1) 99-106
15. Jacobs, M. A.; Barker, P. B.; Argani, P.; Ouwerkerk, R.; Bhujwalla, Z. M.; Bluemke, D. A. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study J. Magn. Reson. Imaging 2005, 21 (1) 23-8
16. Cecil, K. M.; Schnall, M. D.; Siegelman, E. S.; Lenkinski, R. E. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy Breast Cancer Res. Treat. 2001, 68 (1) 45-54
17. 1H MRS at 1.5 T Eur. Radiol. 2005, 15 (5) 1037-43
18. 1H MR spectroscopy Magn. Reson. Med. 2003, 50 (6) 1134-43
19. Jagannathan, N. R.; Kumar, M.; Seenu, V.; Coshic, O.; Dwivedi, S. N.; Julka, P. K.; Srivastava, A.; Rath, G. K. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer Br. J. Cancer 2001, 84 (8) 1016-22
20. Duarte, I. F.; Marques, J.; Ladeirinha, A. F.; Rocha, C.; Lamego, I.; Calheiros, R.; Silva, T. M.; Marques, M. P.; Melo, J. B.; Carreira, I. M.; Gil, A. M. Analytical approaches toward successful human cell metabolome studies by NMR spectroscopy Anal. Chem. 2009, 81 (12) 5023-32
21. Andersson, M. A comparison of nine PLS1 algorithms J. Chemom. 2009, 23, 518-29
22. Trygg, J.; Wold, S. Orthogonal projections to latent structures (O-PLS) J. Chemom. 2002, 16, 119-28
23. Tapp, H. S.; Kemsley, E. K. Notes on the practical utility of OPLS Trends Anal. Chem. 2009, 28, 1322-7
24. 1H NMR metabonomics Anal. Chem. 2006, 78 (13) 4281-90
25. Westerhuis, J. A.; Hoefsloot, H. C. J.; Smit, S.; Vis, D. J.; Smilde, A. K.; van Velzen, E. J. J.; van Duijnhoven, J; van Dorsten, F. A. Assessment of PLSDA cross validation Metabolomics 2008, 4, 81-9
26. Sitter, B.; Sonnewald, U.; Spraul, M.; Fjosne, H. E.; Gribbestad, I. S. High-resolution magic angle spinning MRS of breast cancer tissue NMR Biomed. 2002, 15 (5) 327-37
27. 1H MRS study of human high grade gliomas NMR Biomed. 2004, 17 (4) 191-205
28. Ulrich, E. L.; Akutsu, H; Doreleijers, J. F.; Harano, Y; Ioannidis, Y. E.; Lin, J; Livny, M; Mading, S; Maziuk, D; Miller, Z; Nakatani, E; Schulte, C. F.; Tolmie, D. E.; Wenger, R. K.; Yao, H; Markley, J. L. BioMagResBank Nucleic Acids Res. 2007, 36, D402-8
29. Wishart, D. S.; Knox, C.; Guo, A. C.; Eisner, R.; Young, N.; Gautam, B.; Hau, D. D.; Psychogios, N.; Dong, E.; Bouatra, S.; Mandal, R.; Sinelnikov, I.; Xia, J.; Jia, L.; Cruz, J. A.; Lim, E.; Sobsey, C. A.; Shrivastava, S.; Huang, P.; Liu, P.; Fang, L.; Peng, J.; Fradette, R.; Cheng, D.; Tzur, D.; Clements, M.; Lewis, A.; De Souza, A.; Zuniga, A.; Dawe, M.; Xiong, Y.; Clive, D.; Greiner, R.; Nazyrova, A.; Shaykhutdinov, R.; Li, L.; Vogel, H. J.; Forsythe, I. HMDB: a knowledgebase for the human metabolome Nucleic Acids Res. 2009, 37 (Database issue) D603-10
30. 1H NMR data sets Anal. Chem. 2005, 77 (5) 1282-9
31. 31P correlation NMR study NMR Biomed. 1990, 3 (5) 220-6
32. Cheng, L. L.; Ma, M. J.; Becerra, L.; Ptak, T.; Tracey, I.; Lackner, A.; Gonzalez, R. G.. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy Proc. Natl. Acad. Sci. U.S.A. 1997, 94 (12) 6408-13
33. Futahashi, Y.; Komano, J.; Urano, E.; Aoki, T.; Hamatake, M.; Miyauchi, K.; Yoshida, T.; Koyanagi, Y.; Matsuda, Z.; Yamamoto, N. Separate elements are required for ligand-dependent and -independent internalization of metastatic potentiator CXCR4 Cancer Sci. 2007, 98 (3) 373-9
34. Tarasova, N. I.; Stauber, R. H.; Michejda, C. J. Spontaneous and Ligand-induced Trafficking of CXC-Chemokine Receptor 4 J. Biol. Chem. 1998, 273 (26) 15883-6
35. 1H NMR spectroscopic metabonomic studies Anal. Chem. 2005, 77 (2) 517-26
36. Morse, D. L.; Carroll, D.; Day, S.; Gray, H.; Sadarangani, P.; Murthi, S.; Job, C.; Baggett, B.; Raghunand, N.; Gillies, R. J. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway NMR Biomed. 2009, 22 (1) 114-27
37. Glunde, K.; Jie, C.; Bhujwalla, Z. M. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer Cancer Res. 2004, 64 (12) 4270-6
38. Thomas, M. A.; Lipnick, S.; Velan, S. S.; Liu, X.; Banakar, S.; Binesh, N.; Ramadan, S.; Ambrosio, A.; Raylman, R. R.; Sayre, J.; DeBruhl, N.; Bassett, L. Investigation of breast cancer using two-dimensional MRS NMR Biomed. 2009, 22 (1) 77-91